Ira has over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialisation, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.

Prior to that, employed by SmithKline Beecham Pharmaceuticals working in sales, marketing, and business strategy positions. Ira has also served as Vice President of Corporate Development for the pharmacy benefit management company Prescription Delivery Systems (acquired by Cigna Health Insurance); 

He has an MBA, Temple University and a BS, Pharmacy, Rutgers University. 

He is also a Board Member of RegenerAge SAPI de CV, (www.regenerage.clinic/en/) a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, the Reanima Project (http://www.reanima.tech), member of the Executive Council of the World Academy of Medical Science – WAMS (https://wams.online/our_team/ira-s-pastor/), and member of the World Economic Forum's Human Enhancement council (https://www.weforum.org/people/ira-pastor).

He runs Bioquark, which is focused on the development and commercialisation of a novel range of biologic based products and services that have the ability to alter the biological regulatory state of human tissues and organs, with the goal of curing a wide range of diseases.

Web: http://bioquark.com 

LinkedIn: https://www.linkedin.com/in/iraspastor

Twitter: https://twitter.com/irat1onal 

Facebook company page: https://www.facebook.com/Bioquark  

Facebook profile: https://www.facebook.com/ira.pastor.7